These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6519921)

  • 21. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
    Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
    J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.
    Dunkley ML; Clancy RL; Cripps AW
    Immunology; 1994 Nov; 83(3):362-9. PubMed ID: 7835960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infections with Pseudomonas aeruginosa in the compromised host.
    Frøland SS
    Scand J Infect Dis Suppl; 1981; 29():72-80. PubMed ID: 6797060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of specific delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.
    Colizzi V; Garzelli C; Campa M; Toca L; Falcone G
    Immunology; 1982 Oct; 47(2):337-44. PubMed ID: 6811422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective action of various antibody preparations in experimental bacterial sepsis].
    Trautmann M; Brückner O; Hofstaetter T; Seiler FR; Hahn H
    Beitr Infusionther Klin Ernahr; 1982; 9():155-65. PubMed ID: 6816213
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclophosphamide on the protective action of endotoxin in mice challenged with encephalomyocarditis virus.
    Rathová V; Kocisková D; Borecký L
    Acta Virol; 1972 May; 16(3):201-10. PubMed ID: 4402249
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carbenicillin and gentamicin in experimental Pseudomonas cystitis].
    Prát V; Konicková L; Ritzerfeld W; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):213-6. PubMed ID: 5357863
    [No Abstract]   [Full Text] [Related]  

  • 30. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa mastitis outbreaks in sheep and goat flocks: antibody production and vaccination in a mouse model.
    Leitner G; Krifucks O
    Vet Immunol Immunopathol; 2007 Oct; 119(3-4):198-203. PubMed ID: 17644188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa causing nosocomial meningitis in neonates and children: overview of 15 cases within 10 years.
    Ondrusova A; Kalavsky E; Rudinsky B; Freybergh FP; Bauer F; Miklosko J; Huttova M; Kisac P; Cauda R
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():20-1. PubMed ID: 17558370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of bacteremia due to Pseudomonas aeruginosa in cyclophosphamide-treated mice and potentiation of virulence of endogenous streptococci.
    Brownstein DG
    J Infect Dis; 1978 Jun; 137(6):795-801. PubMed ID: 351090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity of quinoxidine in experimental mennigitis of rabbits caused by Bacillus pyocyaneous].
    Radkevich TP; Padeĭskaia EN; Pershin GN
    Farmakol Toksikol; 1968; 31(3):299-305. PubMed ID: 4972353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Care of pyocyanic meningitis by intrathecal injection of sulfamide].
    Laine E; Jomin M; Carbonnel B; Andreussi L
    Lille Med; 1972 Mar; 17(3):482-4. PubMed ID: 4626049
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies on mice challenged intracerebrally with Pseudomonas aeruginosa.
    Campanile F; Puccetti P; Angeli G; Fioretti MC; Bonmassar E
    Int J Tissue React; 1984; 6(5):421-6. PubMed ID: 6519921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy of anti-endotoxin antibody and gentamicin in the immunosuppressed mice with Pseudomonas aeruginosa infection.
    Haranaka K; Sugane K; Mashimo K
    Jpn J Exp Med; 1975 Jun; 45(3):207-13. PubMed ID: 809609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effectiveness of gentamycin and rifampicin in experimental staphylococcal-Pseudomonas aeruginosa infection and their effect on immunological processes].
    Dnestranskaia LI; Tsyganenko AIa
    Antibiotiki; 1982 Aug; 27(8):626-31. PubMed ID: 6889836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa meningitis following stapedectomy.
    Clairmont AA; Nicholson WL; Turner JS
    Laryngoscope; 1975 Jun; 85(6):1076-83. PubMed ID: 806761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.